Ireland
--:--IST
Latest
Wegovy in Ireland: NCPE Backs It, HSE Decision Still Awaited GSK Q3 2026: Falling Vaccine Sales Dent a Strong Quarter Experic Wins HPRA Licence for Kilbeggan Trial Supply Site Ireland's GDP Grows 5.5% in Q3 as Multinationals Rebound Lilly's Retatrutide Doubles Ozempic Weight Loss in Trial Danny McAuley Named NI Health Chief Scientific Adviser Wegovy in Ireland: NCPE Backs It, HSE Decision Still Awaited GSK Q3 2026: Falling Vaccine Sales Dent a Strong Quarter Experic Wins HPRA Licence for Kilbeggan Trial Supply Site Ireland's GDP Grows 5.5% in Q3 as Multinationals Rebound Lilly's Retatrutide Doubles Ozempic Weight Loss in Trial Danny McAuley Named NI Health Chief Scientific Adviser
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Aurillac
Clinical trial register · France

Clinical Trials in Aurillac, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9731 matching records held by the registry are in this view. Synced 02 Nov 2026, 03:18 UTC
9731
Studies in scope
all four open statuses
6052
Recruiting now
open to new participants
1028
Lead sponsors
across recruiting studies
Top sites
Paris 2829 Lyon 1396 Bordeaux 1393 Marseille 1295 Lille 1283
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Hospital, Clermont-Ferrand5 Federation Francophone de Cancerologie Digestive4 AstraZeneca4 Centre Jean Perrin2 UNICANCER2
Site location
Paris2829 Lyon1396 Bordeaux1393 Marseille1295 Lille1283
All 804 locations
Target enrolment
to

Trials with a site in Aurillac

25 of 9731 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock
NCT07179276Sepsis - to Reduce Mortality in the Intensive Care Unit, Septic Shock
University Hospital, Clermont-Ferrand
Not applicable
750
Angers, Aurillac, Bayonne, Bordeaux, Clermont-Ferrand, Dijon, Grenoble, Le Puy-en-Velay
2026-03-29
Recruiting
Federation Francophone de Cancerologie Digestive
Not applicable
300
Poitiers, Albi, Amiens, Annecy, Aurillac, Bayeux, Bayonne, Beauvais
2026-03-10
Not yet open
Risk of Pneumonia in Intubated Patients in Emergency Situations
NCT07439146Pneumonia, Orotracheal Intubation
University Hospital, Clermont-Ferrand
Observational
600
Aurillac, Clermont-Ferrand, Le Puy-en-Velay, Montluçon, Moulins, Vichy
2026-02-09
Recruiting
UNICANCER
Phase 3
3,902
Amiens, Angers, Argenteuil, Aurillac, Auxerre, Avignon, Bayonne, Beauvais
2025-12-18
Recruiting
Federation Francophone de Cancerologie Digestive
Phase 3
324
Aurillac, Avignon, Bayeux, Bayonne, Bezannes, Bordeaux, Brest, Caen
2025-12-15
Recruiting
Versailles Hospital
Phase 3
674
Amiens, Angers, Annecy, Argenteuil, Aurillac, Brest, Brive-la-Gaillarde, Caen
2025-11-06
Recruiting
Centre Jean Perrin
Not applicable
59
Aurillac, Clermont-Ferrand, Lyon, Saint-Etienne
2025-10-13
Not yet open
Federation Francophone de Cancerologie Digestive
Phase 2
300
Angers, Annecy, Antony, Aurillac, Bayeux, Bayonne, Beauvais, Besançon
2025-08-31
Not yet open
Centre hospitalier Henri Mondor d'Aurillac
Not applicable
27
Aurillac
2025-05-15
Recruiting
Resilience
Phase 3
1,458
Aix-en-Provence, Aurillac, Bayonne, Caen, Clermont-Ferrand, La Tronche, Lille, Lyon
2025-04-01
Recruiting
AstraZeneca
Phase 3
11,300
Amiens, Angers, Aurillac, Besançon, Bobigny, Bois-Guillaume, Brest, Caen
2025-03-14
Recruiting
UNICANCER
Phase 2
400
Amiens, Aurillac, Avignon, Bayeux, Bayonne, Besançon, Caen, Caluire-et-Cuire
2025-01-20
Recruiting
UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
NCT06726720Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
AstraZeneca
Observational
300
Aix-en-Provence, Angers, Aurillac, Auxerre, Avignon, Bezannes, Béziers, Blois
2024-12-16
Recruiting
Vulnerability and Risk of Neuropathic Pain in Cancer
NCT06511674Neuropathic Pain, Cancer, Predictive
University Hospital, Clermont-Ferrand
Not applicable
625
Ajaccio, Angers, Aurillac, Bordeaux, Caen, Clermont-Ferrand, Colmar, Dijon
2024-10-28
Recruiting
Federation Francophone de Cancerologie Digestive
Phase 3
310
Agen, Aix-en-Provence, Amiens, Antony, Argenteuil, Arras, Aurillac, Auxerre
2024-02-26
Recruiting
AstraZeneca
Phase 3
5,250
Aix-en-Provence, Aurillac, Bayonne, Biarritz, Blois, Brest, Cannes, Cherbourg
2024-02-21
Recruiting
Centre Jean Perrin
Not applicable
63
Clermont-Ferrand, Aurillac, Lyon, Saint-Etienne
2024-01-17
Active, closed
University Hospital, Clermont-Ferrand
Not applicable
1,000
Aurillac, Clermont-Ferrand, Grenoble, Le Puy-en-Velay, Lyon, Montbrison, Montluçon, Moulins
2023-10-16
Recruiting
Poitiers University Hospital
Not applicable
670
Angers, Argenteuil, Aurillac, Avignon, Belfort, Bordeaux, Bourg-en-Bresse, Brest
2023-02-02
Recruiting
University Hospital, Clermont-Ferrand
Not applicable
180
Amiens, Aurillac, Bayonne, Bordeaux, Chambéry, Clermont-Ferrand, Grenoble, Issoire
2022-03-21
Active, closed
AstraZeneca
Phase 3
363
Aurillac, Bordeaux, Marseille, Paris, Strasbourg, Toulouse
2022-02-15
Recruiting
European Georges Pompidou Hospital
Observational
3,000
Saint-Denis, Aix-en-Provence, Amiens, Auch, Aurillac, Besançon, Blanquefort, Bobigny
2016-07
Recruiting
UMC Utrecht
Phase 3
20,000
Argenteuil, Aurillac, Beauvais, Belfort, Béthune, Boulogne-Billancourt, Dax, Dieppe
2016-04-11
Active, closed
Acerta Pharma BV
Phase 2
107
Aurillac, Clermond Ferrand, Marseille, Montpellier, Nantes, Paris, Pierre-Bénite, Poitiers
2014-09-11
Recruiting
France PCI Registry : National Observatory of Interventional Cardiology
NCT02778724Interventional, Cardiology, Angioplasty, Coronary
Club Régional des Angioplasticiens de la région Centre
Observational
40,000
Le Coudray, Aurillac, Bourges, Caen, Chambray-lès-Tours, Clermont-Ferrand, Évreux, Le Havre
2014-01
Rows per page Showing 1–25 of 25
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 2 November 2026. https://priyalifescience.com/clinical-trials-france/city/aurillac

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,731 studies in total at the last sync on 02 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 25 of those studies with a site in Aurillac.

How many clinical trials are recruiting in Aurillac?

19 of the 25 studies on this page are recruiting new participants as of the 02 Nov 2026, 03:18 UTC sync. A further 3 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Aurillac), 25 studies
PhaseStudiesRecruitingShare
Not applicable9736%
Phase 39836%
Observational4316%
Phase 23112%

Most active sponsors

Lead sponsors with the most studies (Aurillac)
Lead sponsorStudiesRecruiting
University Hospital, Clermont-Ferrand53
AstraZeneca43
Federation Francophone de Cancerologie Digestive43
Centre Jean Perrin22
UNICANCER22
Acerta Pharma BV10
Centre hospitalier Henri Mondor d'Aurillac10
Club Régional des Angioplasticiens de la région Centre11
European Georges Pompidou Hospital11
Poitiers University Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.